Drugs / Fluticasone furoate/umeclidinium bromide/vilanterol
Fluticasone furoate/umeclidinium bromide/vilanterol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03662711 | Nov 2018 → Oct 2022 | chronic obstructive pulmonary disease | Università degli Studi di Ferrara | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticasone furoate/umeclidinium bromide/vilanterol | “Fluticasone furoate/umeclidinium bromide/vilanterol” NCT03662711 ↗ |